Top compounds associated with response to CEP89


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K45681478 CTRPv2 pan-cancer AAC 0.11 0.004
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.004
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.11 0.005
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.006
mRNA AZD0530 CCLE pan-cancer AAC 0.14 0.006
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.006
mRNA BRD-K44224150 CTRPv2 pan-cancer AAC 0.21 0.007
mRNA Vandetanib CTRPv2 pan-cancer AAC -0.11 0.008
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.097 0.008
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 0.008
Download CSV